Cabergoline Rx

Select the drug indication to add to your list


Pituitary disorders
Only 4 drugs may be compared at once

Generic Name and Formulations:

Cabergoline 0.5mg; scored tabs.

Select therapeutic use:

Indications for Cabergoline:

Hyperprolactinemic disorders, either idiopathic or due to pituitary tumors.


Initially 0.25mg twice weekly. Dose may be increased at 4-week intervals by 0.25mg twice weekly. Max: 1mg twice weekly.


Not recommended.


Uncontrolled hypertension. Sensitivity to ergot alkaloids.


Not for pregnancy-induced hypertension or postpartum lactation inhibition or suppression. Respiratory or cardiac disease due to fibrosis. Hepatic dysfunction. Pregnancy (Cat.B). Nursing mothers: not recommended.

Pharmacological Class:

Dopamine agonist.


Concurrent dopamine D2 antagonists (eg, phenothiazines, butyrophenones, thioxanthines, metoclopramide): not recommended. Hypotension may be potentiated by antihypertensives.

Adverse Reactions:

GI upset, dizziness, fatigue, postural hypotension, nervousness, breast pain, dysmenorrhea, vision abnormalities; rare: fibrosis, valvulopathy.


Formerly known under the brand name Dostinex.

How Supplied:

Contact supplier.